back to top
Search

Pharmaceuticals

Latest Posts

Discover More
Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced first-quarter 2025 monetary outcomes, reporting a rise...
Market

AbbVie Q1 2025 adjusted earnings improve on 8% income development; beat estimates | AlphaStreet

Bristol Myers Squibb (NYSE: BMY) reported web revenue for the primary quarter of 2025,...
Market

Bristol-Myers Squibb swings to revenue in Q1 2025; income drops | AlphaStreet

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings outcomes at the...
Market

JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 monetary outcomes | AlphaStreet

Medical know-how firm AngioDynamics, Inc. (NASDAQ: ANGO) Wednesday reported a narrower internet loss for...
Market

AngioDynamics (ANGO) Q3 2025 loss narrows; gross sales down 4% | AlphaStreet

OS Therapies (NYSE: OSTX) is a most cancers immunotherapy firm engaged within the improvement...
Market

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness | AlphaStreet

Medical gadget maker Medtronic plc (NYSE: MDT) on Tuesday reported a rise in revenues...
Market

MDT Earnings: Medtronic experiences greater Q3 2025 income and adj. revenue | AlphaStreet

Healthcare conglomerate CVS Well being Company (NYSE: CVS) reported blended outcomes for the fourth...
Market

Earnings: CVS Well being studies a pointy fall in This autumn revenue; income up 4% | AlphaStreet

Eli Lilly and Firm (NYSE: LLY) Thursday reported a pointy improve in its fourth-quarter...
Market

LLY Earnings: Eli Lilly This autumn 2024 revenue greater than doubles; income up 45% | AlphaStreet

Pharmaceutical firm Merck & Co. Inc. (NYSE: MRK) reported a pointy enhance in adjusted...
Market

MRK Earnings: Merck This fall 2024 adj. revenue jumps on sturdy gross sales progress | AlphaStreet

Biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) introduced fourth-quarter 2024 monetary outcomes, reporting a double-digit...
Market

AbbVie This autumn 2024 adjusted earnings decline regardless of 6% income development | AlphaStreet

Abbott Laboratories (NYSE: ABT) on Wednesday introduced monetary outcomes for the fourth quarter of...
Market

Highlights of Abbott Laboratories (ABT) This autumn 2024 outcomes | AlphaStreet

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings outcomes as we...
Market

JNJ Earnings: All you must find out about Johnson & Johnson’s This fall 2024 earnings outcomes | AlphaStreet

Faruqi & Faruqi, LLP Securities Litigation Accomplice James (Josh) Wilson Encourages Buyers Who Suffered...
Market

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Buyers of Regeneron Prescription drugs By Investing.com

AngioDynamics Inc. (NASDAQ: ANGO) reported a web loss for the second quarter of 2025...
Market

AngioDynamics (ANGO) reviews web loss for Q2 2025; gross sales drop 8% | AlphaStreet

Gelteq Restricted (NASDAQ: GELS) is a healthcare firm specializing within the improvement and manufacturing...
Market

“Gelteq has been continuously evolving to expand applications and audiences” | AlphaStreet

Depth Therapeutics, Inc. (NASDAQ: INTS) is a medical biotechnology firm engaged within the discovery...
Market

Depth Therapeutics is establishing a brand new discipline of localized most cancers discount: CEO | AlphaStreet

Eli Lilly and Firm (NYSE: LLY) reported its third quarter 2024 earnings outcomes right...
Market

Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights | AlphaStreet

Medical machine firm Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a pointy enhance in...
Market

Intuitive Surgical (ISRG) stories double-digit development in Q3 income and earnings | AlphaStreet

DUBLIN, Sept. 4, 2024 /PRNewswire/ --  Jazz Prescribed drugs plc (Nasdaq: JAZZ) (" Jazz...
Market

Jazz Prescribed drugs Declares Pricing of Non-public Providing of $850 Million of three.125% Exchangeable Senior Notes due 2030 and Concurrent Bizarre Share Repurchases By...

In a latest transaction, Blake Borgeson, a director at Recursion Prescribed drugs, Inc. (NASDAQ:RXRX),...
Market

Recursion Prescribed drugs director sells $81,532 in firm inventory By Investing.com

Eli Lilly and Firm (NYSE: LLY) on Thursday reported a double-digit improve in revenues...
Market

LLY Earnings: Highlights of Eli Lilly’s Q2 2024 monetary report | AlphaStreet

Pharmaceutical firm Merck & Co. Inc. (NYSE: MRK) reported web revenue for the second...
Market

Merck (MRK) swings to revenue in Q2 on increased revenues; earnings beat | AlphaStreet

Biotechnology firm Bristol Myers Squibb (NYSE: BMY) Friday reported larger revenues and web revenue...
Market

BMY Earnings: Bristol-Myers Squibb reviews larger Q2 income and revenue | AlphaStreet

Specialty biopharmaceutical firm AbbVie, Inc. (NYSE: ABBV) Thursday introduced second-quarter 2024 monetary outcomes, reporting...
Market

AbbVie Q2 2024 adj. revenue drops regardless of greater revenues; outcomes beat | AlphaStreet

Useful Links

Topics

Top Coins

Join Us

© 2024 Coin Trolly. All Rights Reserved.